Biomedicine News and Research

RSS

Experimental optimization of prime editing to achieve high efficiency

Genome editing technologies have enormous potential for treating genetic diseases. Techniques like the extensively used CRISPR/Cas9 gene scissors target the source of the disease directly in the DNA.

3 Feb 2023

Clinically approved fungal vaccine protects against fungal infections

A new vaccine developed by the University of Georgia might be the first clinically approved immunization to safeguard against invasive fungal infections, which are becoming more common as antifungal drug resistance grows.

From University of Georgia 1 Feb 2023

Digital microbe database unlocks patient response to treatment

Scientists at the University of Galway, in collaboration with APC Microbiome Ireland, a world-class SFI Research Centre, have developed a database of over 7,000 digital microbes, allowing computer simulations of how drug treatments operate and how patients may respond.

24 Jan 2023

Preventing protein-protein interactions with a new tool

Proteins constantly interact with one another inside cells to perform various tasks. Blocking the binding of two or more proteins appears as a potential treatment for some diseases where these functions are altered.

1 Dec 2022

Acute infection disrupts the healthy balance between the good and bad gut microbes

Rutgers researchers examined the impact of COVID-19 on patients’ microbiomes, the group of microbes that live in and on the human body.

From Rutgers University 30 Nov 2022

European project promotes top-notch research in biochemistry and biophysics

TWIN2PIPSA, a new European project funded with €1.2 million, will support leading research and intensive training in the biochemistry and biophysics of protein folding, with implications and applications in biomedicine and biotechnology.

15 Nov 2022

Role of p53-mediated metabolism in preventing genomic instability

The gene that codes for the protein p53 is most likely the most significant factor in defending human cells against DNA-damaging agents that cause cancer. The protein permits cells to repair DNA damage and so prevents the formation of malignancies, earning it the nickname “guardian of the genome.”

4 Nov 2022

Quantifying microanatomical tissue structures without human intervention

Scientists at Weill Cornell Medicine have created a computational method for mapping the architecture of human tissues in extraordinary detail. Their method guarantees to expedite research on organ-scale cellular interactions and could lead to strong new diagnostic strategies for a variety of disorders.

1 Nov 2022

Rutgers researchers seek to develop technology for protein editing

Rutgers researchers are seeking to develop the technology to modify or "edit" protein molecules in the body-;an advance that could spur major breakthroughs in human health.

From Rutgers University 26 Sep 2022

An analysis of old genes’ influence on sea anemones

For the neuronal cell types’ categorization as more complicated creatures, the genetic fingerprint of Nematostella vectensis—the sea anemone—reveals that the members of this evolutionarily very ancient animal phylum employ identical gene cascades.

22 Sep 2022

New imaging technologies to evade immune responses of Candida albicans

Researchers from the Monash Biomedicine Discovery Institute have demonstrated how the common fungus Candida albicans evades immune responses using newly discovered imaging technologies. The researchers claim that this involves a fungus that can shape-shift in an “alien-like” manner to escape immune cells.

21 Sep 2022

Scientists uncover the robust mechanism used by insects

Researchers at IRB Barcelona, under the direction of Dr Marco Milan, have identified a very robust system that insects use for wing formation and regeneration.

25 Aug 2022

A more environmentally friendly way to produce widely used artificial organic dyes

Organic, i.e. carbon-containing dyes have important roles in nature. For example, they are responsible for transporting oxygen and other gases in the body (as part of hemoglobin) and converting solar energy into chemical energy in photosynthesis (chlorophyll).

22 Aug 2022

Study provides guidelines on how to design safer CRISPR reagents

The 2020 Nobel Prize in Chemistry was awarded to Jennifer A. Doudna and Emmanuelle Charpentier for developing the widely utilized and incredibly precise genome editing method known as CRISPR/Cas9

11 Aug 2022

Cedars-Sinai builds bio-realistic and intricate computer models of brain cells

Researchers at Cedars-Sinai have produced an unprecedented number of bio-realistic and intricate computer models of individual brain cells.

11 Aug 2022

Researchers understand the processes that affect the efficiency of the CRISPR method

When it comes to the ability of genetic engineering, the only restriction is the human imagination, particularly since the discovery of CRISPR technology.

1 Jul 2022

Researchers get deep insights into the functionality of human genome

Scientists from Weill Cornell Medicine and the New York Genome Center, in partnership with Oxford Nanopore Technologies, have introduced a new method for assessing the three-dimensional structure of the human genome, as well as how the genome folds, on a large scale.

27 Jun 2022

Stanford scientists develop fingertip-sized millirobots to improve targeted drug delivery

If you've ever swallowed the same round tablet in hopes of curing everything from stomach cramps to headaches, you already know that medicines aren't always designed to treat precise pain points.

17 Jun 2022

Intracellular microbiota promote cell survival during tumor progression

Bacteria promote cancer metastasis by bolstering the strength of host cells against mechanical stress in the bloodstream, promoting cell survival during tumor progression, researchers report April 7th in the journal Cell.

8 Apr 2022

New scalable method to advance maturation of human pluripotent stem cell-derived cardiomyocytes

A Mount Sinai-led team has developed a reproducible and scalable method to advance maturation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs)-;cells that support heart muscle contraction, generated in the lab from human stem cell lines-;which researchers say will improve approaches for disease modeling, regenerative therapies, and drug testing.

8 Apr 2022